Study Name Principal Investigator
(ALA Cogn) Effect of 6 weeks of Alpha-Lipoic Acid Supplementation on Cognitive and Vascular Function in Older Adults Robinson, Vincent
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(CONGA) COVID-19 Neurological and Molecular Prospective Cohort Study in Georgia Rutkowski, Elizabeth
(Eisai 238) An open-label study with an extension phase to evaluate the pharmacokinetics of perampanel (E2007) oral suspension when given as an adjunctive therapy in subjects from 1 month to less than 24 months (<2 years) of age with epilepsy Park, Yong
(MSK-002 MG) A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients Pruitt, J. Ned
(NO1269 Absence) Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy Park, Yong
(PISCES III Stroke) A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in subjects with Disability Following an Ischemic Stroke (PISCES III) Switzer, Jeffrey
(Premier LGS C001) Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Carisbamate in Adult and Pediatric Subjects with Lennox-Gastaut Syndrome Park, Yong
A Multicenter, Randomized, Subject-blinded, Investigator-blinded, Placebo-controlled, Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Rivner, Michael
A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) McEvoy, Joseph
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) Rivner, Michael
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis Rivner, Michael
A Phase 2a Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Multiple Doses of AT-1501 in Adults with ALS Rivner, Michael
A PHASE 2B/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 MONTH CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MN-166 (IBUDILAST) FOLLOWED BY AN OPEN-LABEL EXTENSION IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS Rivner, Michael
A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis Rivner, Michael
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis Rivner, Michael
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Na´ve Adult Patients With Generalized Myasthenia Gravis Rivner, Michael
A Prospective Observational Multicenter Study of HF10 Therapy in Patients Who Previously Failed Traditional SCS (RENEW) Dua, Anterpreet
A Randomized Controlled Trial of Adjunctive Siltuximab in Schizophrenia Miller, Brian
A RANDOMIZED, DOUBLE-BLIND, MULTICENTER,PLACEBO-CONTROLLED PHASE 3 STUDY WITH OPEN-LABEL PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF INEBILIZUMAB IN ADULTS WITH MYASTHENIA GRAVIS Rivner, Michael
Amifampridine for the Treatment of Transient Vocal Weakness after OnabotulinumtoxinA Injection for Spasmodic Dysphonia Rivner, Michael
AN OPEN-LABEL EXTENSION STUDY TO EVALUATE ROZANOLIXIZUMAB IN STUDY PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS Rivner, Michael
Assessing post-concussion syndrome in athletes with the use of pupillometry. McLane, Tim
Augmentation versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD) McCall, Vaughn
CDX1140-01: A Phase 1 Study of CDX-1140, a Fully Human Agonist anti-CD40 Monoclonal Antibody, as Monotherapy or in Combination in Patients with Advanced Malignancies Kota, Vamsi
CSF flow rate through cerebral aqueduct as an approximation for CSF production and absorption determined by MRI techniques Macomson, Samuel
Development and psychometric evaluation of a brain fogginess symptoms questionnaire: The BFSQ Rao, Satish
Developmental Gene Discovery Project: Mapping and Identifying New Genes in Uterine and Vaginal Development; Identifying New Genes Causing Birth Defects in Children Layman, Lawrence
Differences in Postural Control during the Single-Limb Romanian Deadlift using the Dominant vs Non-Dominant Limb during Weighted and Weighted Conditions Hogan, Valerie
GCC2020: Repurposing ibrutinib for chemo-immunotherapy in a phase 1b study of ibrutinib with indoximod plus metronomic cyclophosphamide and etoposide for pediatric patients with brain cancer Johnson, Theodore
Influenza Vaccination in Schizophrenia Miller, Brian
Intermittent Fasting in Tactical Athletes Holland, Angelia
Kadmon KD025-013: A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study) Kota, Vamsi
Knowledge Translation of Remotely Delivered Task Oriented Training for Stroke Rehabilitation (reTOTE- Remote Task Oriented Training and Evaluation) Carrick, Ryan
Language Development in Preterm Infants Williams, Bryan
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies Rivner, Michael
NAPS: Niacin for Parkinson's Disease Wakade, Chandramohan
NMTRC 014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO) McDonough, Colleen
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Pilot Studies in Pupillometry in Suicidal and non-Suicidal Patients McCall, Vaughn
RBC Deformability in Acute Stroke Singh, Dilip
Schizophrenia Research Database McEvoy, Joseph
SOFAST: SOFia Aspiration System as first line Technique Rahimi, Scott
Study to evaluate the safety, tolerability, and efficacy of ganglioside administration for neurodegenerative diseases Yu, Robert
Testing GPi deep brain stimulation devices for their ability to modify brain blood flow Blake, David
The ShOP Study (Shopping in Older Adults Project) Lehman, Leigh
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study Sharma, Amol
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL Rao, Satish
Understanding the Genetic Basis of Transgender Identity Layman, Lawrence
Utility of Pre-Operative Stellate Ganglion Blockade for Pain Control in Unilateral Head and Neck Cancer Surgery Byrd, Kenneth
RESEARCH. INNOVATION. DISCOVERY.